318165003: Bumetanide+potassium 500mcg/7.7Mmol m/r tablet (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2153200010 Bumetanide+potassium 500mcg/7.7Mmol m/r tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

2160831012 Bumetanide+potassium 500mcg/7.7Mmol m/r tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

4740841000005119 bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning	Is a	diuretika med kalium	false	Inferred relationship	Some
bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Diuretic (substance)	false	Inferred relationship	Some
bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning	Is a	Product containing bumetanide and potassium (medicinal product)	false	Inferred relationship	Some
bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Potassium	false	Inferred relationship	Some
bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Bumetanide (substance)	false	Inferred relationship	Some
bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning	Has manufactured dose form	A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.	false	Inferred relationship	Some
bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning	Has manufactured dose form	Oral tablet	false	Inferred relationship	Some
bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning	Is a	Product containing bumetanide in oral dose form (medicinal product form)	false	Inferred relationship	Some
bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning	Has manufactured dose form	Modified-release oral tablet (dose form)	false	Inferred relationship	Some
bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning	Is a	Product containing potassium in oral dose form (medicinal product form)	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)